Active lifestyle — cardiovascular health and longevity
Cleerly® + CCTA · Now in San Francisco

Know Your Heart.
See the Evidence.

Cleerly® AI analysis paired with Coronary CT Angiography translates your cardiovascular risk into a direct, quantified view of what's actually present in your coronary arteries — not estimated, visualized.

Why This Matters

Cardiovascular disease is the leading cause of death worldwide.

~50%

No Prior Symptoms

Nearly half of individuals who experience a cardiac event have no prior warning signs. Cardiovascular risk is often silent.

#1

Cause of Death, Globally

Despite decades of advancement, cardiovascular disease remains the single leading cause of death worldwide.

Plaque progresses

Even Without Symptoms

Risk is not static. Plaque can develop and progress over time — even when previous results appeared reassuring.

What Is Cleerly

AI that sees what standard tests cannot.

An FDA-cleared platform that uses advanced imaging and artificial intelligence to evaluate your coronary arteries in precise, quantified detail.

01Technology

FDA-Cleared AI Analysis

Cleerly is FDA-cleared and rigorously validated — not experimental. It applies AI to detailed coronary imaging to produce quantified, reproducible assessments of plaque in each coronary segment.

FDA-Cleared

AI-Powered Quantification

02Imaging

Coronary CT Angiography

CCTA provides non-invasive, high-resolution imaging of the coronary arteries — allowing Cleerly's AI to analyze each vessel with a level of detail not possible through standard testing.

Non-Invasive

High-Resolution

03Insight

Plaque Characterization

Cleerly identifies and quantifies both calcified and non-calcified plaque — the kind most associated with cardiac risk but invisible to standard calcium scoring.

Calcified plaque quantified

Non-calcified plaque identified

How It Builds on Your Care

Beyond risk factors — into actual disease.

Traditional assessments estimate risk. Cleerly directly visualizes plaque within the coronary arteries — complementing your existing evaluations with something they cannot provide on their own.

Traditional Approach

Blood lipids & biomarkers

Genomic risk scores

CT Calcium Score (CAC)

Family history review

Estimates risk. Does not visualize disease.

Now Available

With Cleerly + CCTA

Direct coronary artery visualization

Calcified plaque quantification

Non-calcified plaque identification

AI-generated plaque burden report

Directly visualizes disease. Informs personalized care.

Who May Benefit

Is this evaluation right for you?

You may be a strong candidate if you have any of the following:

  • Prior or elevated calcium score
  • Family history of cardiovascular disease
  • Abnormal cholesterol or lipid biomarkers
  • Known genetic predisposition
  • Hypertension, diabetes, or metabolic conditions

Clinical appropriateness is determined through a physician consultation.

What This Helps Inform

From risk to clear action.

Every finding translates into a concrete clinical direction — not a number to worry about, but a path forward.

01

Precise Risk Stratification

Translate risk factors into a quantified picture of actual coronary plaque burden — moving beyond probability into direct visualization.

02

Therapy Decision Support

Inform whether preventive therapies should be initiated, adjusted, or held based on what is actually present in the arteries.

03

Personalized Recommendations

Support targeted lifestyle and clinical guidance grounded in your individual plaque characterization, not population averages.

What to Expect

Guided end-to-end by your clinical team.

Every step is managed by our physicians — from the initial consultation to a comprehensive walkthrough of your results.

01Consultation

Physician Review

Your clinical team reviews your cardiovascular risk profile, history, and prior findings to determine if CCTA with Cleerly analysis is appropriate for you.

02Imaging

CCTA + Cleerly Analysis

A Coronary CT Angiography is performed and analyzed using Cleerly's FDA-cleared AI platform — identifying, characterizing, and quantifying plaque in each coronary segment.

03Results

Comprehensive Review

Your care team walks you through every finding in detail — what was detected, what it means, and what concrete next steps look like for you.

Active lifestyle — cardiovascular health

The Full Picture

Cleerly is one part of a complete health system.

Human Longevity members receive an integrated view of health that combines whole genome sequencing, whole body MRI, 100+ biomarkers, and Longevity AI — with Cleerly as an advanced layer for those who need deeper cardiovascular insight.

Availability

Initial rollout with limited availability. San Diego launching soon.

San Francisco

Available Now

San Diego

Launching Soon

Book your consultation
or message your care team.

Schedule directly with our clinical team, or reach us anytime through the Personal Longevity Intelligence Platform app.